http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5034406-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
filingDate 1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a62d9e27a534a44dc3ec8cb4aad4a07
publicationDate 1991-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5034406-A
titleOfInvention Method for reducing or maintaining intraocular pressure
abstract The invention relates to the use of a compound of the formula (1): <CHEM> and salts and mixtures thereof; wherein R1 is C1-3 alkyl, R2 is hydrogen or C1-5alkyl, n is 2 to 4, each x is independently 1 or 2, the hydrocarbon ring optionally including a double bond in a position other than the alpha-beta position; for the manufacture of a medicament for reducing or maintaining the intraocular pressure in a mammalian eye, e.g. for treating glaucoma.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6329369-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6841684-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5587376-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965620-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5703077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5714486-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5773440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5552403-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6323204-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5561132-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9924411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005119461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5629345-A
priorityDate 1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3676798-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3598833-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4861760-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129769312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128362287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13020083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127734565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID238663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128977994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251

Total number of triples: 54.